We provide you with 20 years of free, institutional-grade data for NTRA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NTRA. Explore the full financial landscape of NTRA stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-08 | 0001604821 | NTRA | 10-Q | Url |
2025-05-09 | 0001604821 | NTRA | 10-Q | Url |
2025-02-28 | 0001604821 | NTRA | 10-K | Url |
2024-11-12 | 0001604821 | NTRA | 10-Q | Url |
2024-08-09 | 0001604821 | NTRA | 10-Q | Url |
2024-05-10 | 0001604821 | NTRA | 10-Q | Url |
2024-02-29 | 0001604821 | NTRA | 10-K | Url |
2023-11-09 | 0001604821 | NTRA | 10-Q | Url |
2023-08-04 | 0001604821 | NTRA | 10-Q | Url |
2023-05-10 | 0001604821 | NTRA | 10-Q | Url |
2023-03-01 | 0001604821 | NTRA | 10-K | Url |
2022-11-09 | 0001604821 | NTRA | 10-Q | Url |
2022-08-05 | 0001604821 | NTRA | 10-Q | Url |
2022-05-06 | 0001604821 | NTRA | 10-Q | Url |
2022-02-25 | 0001604821 | NTRA | 10-K | Url |
2021-11-05 | 0001604821 | NTRA | 10-Q | Url |
2021-08-06 | 0001604821 | NTRA | 10-Q | Url |
2021-05-07 | 0001604821 | NTRA | 10-Q | Url |
2021-02-26 | 0001604821 | NTRA | 10-K | Url |
2020-11-06 | 0001604821 | NTRA | 10-Q | Url |
2020-08-07 | 0001604821 | NTRA | 10-Q | Url |
2020-05-08 | 0001604821 | NTRA | 10-Q | Url |
2020-03-02 | 0001604821 | NTRA | 10-K | Url |
2019-11-08 | 0001604821 | NTRA | 10-Q | Url |
2019-08-09 | 0001604821 | NTRA | 10-Q | Url |
2019-05-10 | 0001604821 | NTRA | 10-Q | Url |
2019-03-15 | 0001604821 | NTRA | 10-K | Url |
2018-11-09 | 0001604821 | NTRA | 10-Q | Url |
2018-08-09 | 0001604821 | NTRA | 10-Q | Url |
2018-05-10 | 0001604821 | NTRA | 10-Q | Url |
2018-03-15 | 0001604821 | NTRA | 10-K | Url |
2017-11-09 | 0001604821 | NTRA | 10-Q | Url |
2017-08-09 | 0001604821 | NTRA | 10-Q | Url |
2017-05-10 | 0001604821 | NTRA | 10-Q | Url |
2017-03-16 | 0001604821 | NTRA | 10-K | Url |
2016-11-14 | 0001604821 | NTRA | 10-Q | Url |
2016-08-11 | 0001604821 | NTRA | 10-Q | Url |
2016-05-13 | 0001604821 | NTRA | 10-Q | Url |
2016-03-24 | 0001604821 | NTRA | 10-K | Url |
2015-11-13 | 0001604821 | NTRA | 10-Q | Url |
2015-08-13 | 0001604821 | NTRA | 10-Q | Url |
2015-06-01 | 0001604821 | NTRA | S-1 | Url |
Natera, Inc(NASDAQ:NTRA)

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single...
Website: http://www.natera.com
Founded: 2004
Full Time Employees: 1,039
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about NTRA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.